Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

AMREF HEALTH AFRICA

UEI: YDV7JLMNZ178CAGE: SYB53

AMREF HEALTH AFRICA is a federal contractor, registered under UEI YDV7JLMNZ178 and CAGE code SYB53. It has been awarded $200,270,350 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Agency For International Development, Department Of Health And Human Services, and Agency For International Development (usaid).

Contact Information

Registration and classification details

Registration

UEI Code

YDV7JLMNZ178

CAGE Code

SYB53

Entity Structure

Other

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

923120Administration of Public Health Programs(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

AMREF HEALTH AFRICA specializes in the administration of public health programs, delivering strategic support to government-led health initiatives with a focus on system strengthening, program coordination, and public health infrastructure development. Their technical expertise centers on designing ...

AMREF HEALTH AFRICA specializes in the administration of public health programs, delivering strategic support to government-led health initiatives with a focus on system strengthening, program coordination, and public health infrastructure development. Their technical expertise centers on designing and managing complex health program frameworks, including surveillance systems, workforce capacity building, and cross-sectoral health policy implementation. The organization demonstrates a clear specialization in operationalizing public health interventions in resource-constrained environments, leveraging field-based delivery models and data-informed decision-making to enhance health outcomes. Their approach integrates local stakeholder engagement with institutional governance, ensuring sustainable program adoption and alignment with national health priorities. The contractor’s primary agency relationship is with the Department of State, where they support international public health programs that align with U.S. foreign policy and global health security objectives. This engagement suggests a focus on transnational health initiatives, including disease prevention, emergency response coordination, and health system resilience building in partner nations. The nature of the award indicates a sustained partnership centered on program administration rather than direct service delivery, implying expertise in contract management, reporting compliance, and multi-stakeholder coordination across diplomatic and health channels. The contractor operates under NAICS 923120, which encompasses the oversight and administration of public health programs—distinct from direct clinical care or biomedical research. This positions them as a programmatic enabler within the public health ecosystem, facilitating policy execution, resource allocation, and interagency alignment. Their market positioning is niche, serving governmental entities engaged in global health diplomacy and institutional capacity development. AMREF HEALTH AFRICA is structured as a ZZ entity, indicating a non-traditional or international organizational classification under U.S. government contracting frameworks. The organization is headquartered in Nairobi, with operations likely extending across sub-Saharan Africa. No federal certifications are listed, suggesting their market access is based on demonstrated programmatic competence rather than formal small business or socio-economic status designations. Their presence reflects a specialized, regionally grounded capability in international public health administration.

Key Performance Metrics

Awards Count

21

All time

Active

1

Currently performing

Completed

20

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Export
- Unknown NAICS$200.3M100%
Awards by Agency Over Time
Awards by Place of Performance

Compete with AMREF HEALTH AFRICA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for AMREF HEALTH AFRICA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in AMREF HEALTH AFRICA's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding for U.S. small business concerns (SBCs) to conduct research and development of commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants must be for-profit entities located in the U.S., owned more than 50 percent by U.S. citizens or permanent residents, and employ no more than 500 people. The program accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being NIH-specific options to accelerate development. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on an overall impact score, considering commercial potential, technical feasibility, and the quality of the commercialization plan. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines; notably, several institutes, including NIAID and NIAMS, do not accept clinical trials under this NOFO. Applicants must maintain active registrations in SAM, possess a Unique Entity Identifier, and comply with cybersecurity incident reporting requirements, including notifying HHS within 48 hours of a discovery.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on establishing technical merit and feasibility, and Phase II advancing the project toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with the latter two being specific to the NIH. Budget limits vary by participating institute, with Phase I awards typically ranging from 400,000 to 700,000 dollars and Phase II awards reaching up to 3,000,000 dollars. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the environment for success. While clinical trials are generally optional, they are prohibited for specific components, including all FDA centers and several NIH institutes such as NIAMS and NIDCR. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. All applications must be submitted electronically, with a final expiration date of April 06, 2027.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage research and development to full commercialization. This program is specifically available to recipients of prior or active NIH SBIR or STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including technical assistance for regulatory and intellectual property strategies, manufacturing scale-up, independent replication of key studies, and clinical trials. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible applicants must be for-profit organizations with no more than 500 employees and maintain active registrations in the System for Award Management and the SBA Company Registry. Project periods are limited to a maximum of three years, with budget ceilings varying by participating Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via NIH peer review based on scientific and technical merit, commercial potential, and relevance to program priorities. Key submission requirements include a detailed regulatory plan and a CRP progress report, while costs for patent or FDA filing fees and separate Technical and Business Assistance funding are strictly prohibited.
Department of Health and Human Services

POSTED

5 months ago

DEADLINE

in 6 months
View Details